Skip to main content

High-Impact Hepatology: An Update on Care of the Patient with Liver Disease

November 9, 2022

Register Here 20th Annual Hepatology Symposium A hybrid – live in-person and virtual – conference!   The practice of clinical Hepatology remains challenging for many gastroenterologists due to rapidly changing disease management paradigms and often complex, critically-ill patients. The 20th Annual High Impact Hepatology program is specifically designed to bring the latest information from national … Continued

Dr. Moon Awarded Two Liver Cancer Research Grants

October 12, 2022

Andrew Moon, MD, MPH, assistant professor of medicine in the Division of Gastroenterology and Hepatology and member of UNC’s Lineberger, recently received two grants to advance his training in liver cancer research. The American Association for the Study of Liver Diseases presented Moon with a Clinical, Translational and Outcomes Research Award, a two-year $200,000 grant, … Continued

Spencer Dorn Explains Four Ways to Improve Specialty Health Care in the U.S.

June 14, 2022

Spencer D. Dorn, MD, MPH, MHA, a professor of medicine in the Division of Gastroenterology and Hepatology and vice chair for care innovation in the Department of Medicine, wrote this article in Harvard Business Review. Summary: The current structure of specialty care in the United States makes it less accessible, increases costs, tarnishes patients’ experiences, … Continued

Achieving ‘Distant Presence’ During Virtual Visits

March 9, 2022

Today’s clinicians are challenged to remain fully attentive to and engaged with the patients they serve, whether seeing them in person or from a distance. Dr. Spencer Dorn, professor and vice chair for innovation in the department of medicine, recently published a perspective on achieving ‘distant presence’ during virtual visits. Read the article, published by STAT.

Dellon Discusses Dupixent (Dupilumab) Study

March 9, 2022

Evon S. Dellon, MD, MPH, professor in the department of medicine’s division of gastroenterology and hepatology, discussed the Phase 3 LIBERTY-EoE-TREET study for Dupixent (Dupilumab). The results were presented at the American Academy of Allergy, Asthma & Immunology’s Annual Meeting. Read more.    

Crockett Study Considers Value of Endoscopic Clipping After Resection in Large Serrated Polyps

January 9, 2022

Among patients with large serrated polyps, the risk for bleeding after endoscopic mucosal resection was low, with no significant benefit seen with resection clipping, according to a study. “[This] study suggests that endoscopic clipping is not necessary to prevent post-polypectomy bleeding after [endoscopic mucosal resection] of large serrated polyps,” Seth D. Crockett, MD, MPH, associate … Continued

High GI Spending Reveals Research, Public Health Need

December 28, 2021

MD Edge, Internal Medicine reports GI, liver, and pancreatic diseases cost the U.S. health care system about $120B per year and account for approximately 250,000 annual deaths, according to a “conservative” estimate from a recent analysis. These figures emphasize the need for more research funding in the area, along with additional clinical and public health … Continued

Peery Lead Author of Study on Burden and Cost of GI, Liver and Pancreatic Diseases

December 20, 2021

Anne Peery, MD, MSCR, associate professor in the Division of Gastroenterology and Hepatology, is the corresponding author of a new article, “Burden and Cost of Gastrointestinal, Liver and Pancreatic Diseases in the United States: Update 2021,” published October 19 in Gastroenterology. The study concluded, “Gastrointestinal diseases are responsible for millions of health care encounters and … Continued